|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2002-7-31
|
|
pubmed:abstractText |
To conduct an evidence-based technology assessment to determine whether the routine use of anastrozole or any of the aromatase inhibitors in the adjuvant breast cancer setting is appropriate for broad-based conventional use in clinical practice. POTENTIAL INTERVENTIONS: Anastrozole, letrozole, and exemestane.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BraunSusanS,
pubmed-author:BrowmanGeorge PGP,
pubmed-author:BursteinHarold JHJ,
pubmed-author:ChlebowskiRowan TRT,
pubmed-author:CobleighMelody AMA,
pubmed-author:EdgeStephen BSB,
pubmed-author:GoldsteinLori JLJ,
pubmed-author:GralowJulieJ,
pubmed-author:HudisCliffordC,
pubmed-author:IngleJames NJN,
pubmed-author:LangerAmy SAS,
pubmed-author:MamounasEleftherios PEP,
pubmed-author:PerottiJudyJ,
pubmed-author:PowlesTrevor JTJ,
pubmed-author:PritchardKathleen IKI,
pubmed-author:WhelanTimothy JTJ,
pubmed-author:WinerEric PEP
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3317-27
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12149306-Antineoplastic Agents, Hormonal,
pubmed-meshheading:12149306-Aromatase Inhibitors,
pubmed-meshheading:12149306-Breast Neoplasms,
pubmed-meshheading:12149306-Chemotherapy, Adjuvant,
pubmed-meshheading:12149306-Disease-Free Survival,
pubmed-meshheading:12149306-Enzyme Inhibitors,
pubmed-meshheading:12149306-Evidence-Based Medicine,
pubmed-meshheading:12149306-Expert Testimony,
pubmed-meshheading:12149306-Female,
pubmed-meshheading:12149306-Humans,
pubmed-meshheading:12149306-Nitriles,
pubmed-meshheading:12149306-Postmenopause,
pubmed-meshheading:12149306-Randomized Controlled Trials as Topic,
pubmed-meshheading:12149306-Survival Analysis,
pubmed-meshheading:12149306-Tamoxifen,
pubmed-meshheading:12149306-Triazoles
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
|
|
pubmed:affiliation |
Health Services Research Department, American Society of Clinical Oncology, 1900 Duke Street, Suite 200, Alexandria, VA 22314, USA. guidelines@asco.org
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
